Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic

K Dam1, S J Garcia, F J Seidler

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Box 3813 DUMC, Durham, NC 27710, USA.

Insights

Chlorpyrifos (CPF) exposure in neonatal rats disrupts brain development, affecting both cholinergic and catecholaminergic pathways. This developmental neurotoxicity suggests a prolonged vulnerability window for children.

Area of Science:

  • Neuroscience
  • Developmental Toxicology
  • Environmental Health

Background:

  • Infant and child exposure to chlorpyrifos (CPF) can exceed safe levels following routine home use.
  • Developmental neurotoxicity of pesticides is a significant public health concern.

Purpose of the Study:

  • To investigate the effects of early-life chlorpyrifos (CPF) exposure on the developing cholinergic and catecholaminergic systems in neonatal rats.
  • To determine the impact of CPF on synaptic development and function during critical periods of synaptogenesis.

Main Methods:

  • Neonatal rats were treated with CPF on postnatal days 1-4 or 11-14 at doses that did not cause overt toxicity.
  • Choline acetyltransferase (ChAT) activity and hemicholinium-3 (HC-3) binding were measured as indices of cholinergic synapse development and activity.
  • Catecholamine pathways (norepinephrine, dopamine) were assessed via transmitter turnover to evaluate synaptic activity.

Main Results:

  • CPF exposure altered cholinergic function differently in the forebrain and brainstem depending on the timing of exposure.
  • Both early and late CPF treatments increased catecholamine synaptic activity (transmitter turnover).
  • The cerebellum showed the most significant effects, and impacts on catecholamine systems were independent of cholinesterase inhibition levels.

Conclusions:

  • Postnatal CPF exposure disrupts the development of both cholinergic and catecholaminergic pathways during synaptogenesis.
  • These disruptions suggest a critical window of developmental vulnerability to CPF that may extend into childhood.
  • CPF's neurodevelopmental effects highlight the need for caution regarding pesticide exposure in early life.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...